Two Sigma Investments
AKRO

Two Sigma Investments’s Akero Therapeutics AKRO Stock Holding History

Two Sigma Investments’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-62,020
Closed -$2.51M – 3163
2025
Q1 		$2.51M Sell
62,020
-65,300
-51% -$2.77M 0.01% 1596
2024
Q4 		$3.54M Buy
127,320
+38,500
+43% +$1.17M 0.01% 1328
2024
Q3 		$2.55M Sell
88,820
-31,254
-26% -$815K 0.01% 1518
2024
Q2 		$2.82M Buy
120,074
+75,787
+171% +$1.62M 0.01% 1322
2024
Q1 		$1.12M Buy
+44,287
New +$1.06M ﹤0.01% 1885
2023
Q4 		– Sell
-33,800
Closed -$1.71M – 3122
2023
Q3 		$1.71M Hold
33,800
– – ﹤0.01% 1516
2023
Q2 		$1.58M Sell
33,800
-200
-0.6% -$9.16K ﹤0.01% 1641
2023
Q1 		$1.3M Sell
34,000
-8,322
-20% -$371K ﹤0.01% 1719
2022
Q4 		$2.32M Sell
42,322
-91,225
-68% -$3.91M 0.01% 1246
2022
Q3 		$4.55M Buy
133,547
+66,911
+100% +$1.02M 0.02% 795
2022
Q2 		$630K Sell
66,636
-10,424
-14% -$109K ﹤0.01% 1732
2022
Q1 		$1.09M Buy
77,060
+57,560
+295% +$1.01M ﹤0.01% 1669
2021
Q4 		$412K Sell
19,500
-61,471
-76% -$1.36M ﹤0.01% 3421
2021
Q3 		$1.81M Sell
80,971
-81,446
-50% -$1.84M ﹤0.01% 2085
2021
Q2 		$17.2M Sell
162,417
-29,331
-15% -$824K 0.04% 552
2021
Q1 		$5.56M Sell
191,748
-23,836
-11% -$722K 0.01% 976
2020
Q4 		$5.56M Buy
215,584
+149,096
+224% +$4.15M 0.02% 867
2020
Q3 		$2.05M Buy
66,488
+47,471
+250% +$1.66M 0.01% 1284
2020
Q2 		$474K Buy
+19,017
New +$435K ﹤0.01% 2035

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments's AKRO Position: Q2 2025 in Review

Two Sigma Investments sold out of Akero Therapeutics (AKRO) in Q2 2025, closing a stake of 62,020 shares — an estimated $2.51M sold.

Two Sigma Investments first reported a position in AKRO in Q2 2020 and held it in 19 quarters. The position peaked at $17.2M in Q2 2021. 257 funds tracked by Wall St. Rank hold AKRO as of Q2 2025.

  • Two Sigma Investments reported no remaining Akero Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Investments sold 62,020 Akero Therapeutics shares in Q2 2025, an estimated $2.51M.
  • Two Sigma Investments first reported a position in Akero Therapeutics in Q2 2020 and held it in 19 quarters.
  • Two Sigma Investments's Akero Therapeutics position peaked at $17.2M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.